Cancer treatment

Cancer treatment encompasses a wide array of therapeutic strategies aimed at controlling or eliminating cancerous cells within the body. These strategies include chemotherapy, radiation therapy, immunotherapy, targeted therapy, and surgical interventions. Each treatment modality targets different aspects of cancer cell biology, such as cell division, DNA replication, or immune evasion. Research in cancer treatment focuses on improving the efficacy, specificity, and safety of these therapies to enhance patient outcomes and reduce side effects. At CymitQuimica, we provide a comprehensive range of compounds and reagents to support your research in developing innovative and effective cancer treatments.

20
- 50
- 100
- 200

products per page. 984 products on this category.

Product data	Purity	Price range	Estimated delivery
Nintedanib Impurity 76 REF: 4Z-N-066087	- - -	To inquire	Thu 19 Dec 24
Fulvestrant Impurity 6 REF: 4Z-F-3120	- - -	To inquire	Thu 19 Dec 24
Nintedanib Impurity 53 REF: 4Z-N-066071	- - -	To inquire	Thu 19 Dec 24
Lenvatinib Impurity 50 REF: 4Z-L-124057CAS: 2412398-76-4	- - -	To inquire	Thu 19 Dec 24
Leuprorelin (Leuprolide) EP Impurity J REF: 4Z-PL-4112	- - -	To inquire	Thu 19 Dec 24
Olaparib Impurity 74 REF: 4Z-O-032080CAS: 63964-50-1	- - -	To inquire	Thu 19 Dec 24
Olaparib Impurity 77 REF: 4Z-O-032083CAS: 2630919-53-6	- - -	To inquire	Thu 19 Dec 24
Carfilzomib Impurity 81 REF: 4Z-C-121086	- - -	To inquire	Thu 19 Dec 24
Olaparib Impurity 79 REF: 4Z-O-032085CAS: 2558-18-1	- - -	To inquire	Thu 19 Dec 24
Olaparib Impurity 78 REF: 4Z-O-032084	- - -	To inquire	Thu 19 Dec 24
Enzalutamide Impurity 35 REF: 4Z-E-068048	- - -	To inquire	Thu 19 Dec 24
Olaparib Impurity 76 REF: 4Z-O-032082CAS: 763114-25-6	- - -	To inquire	Thu 19 Dec 24
Fulvestrant Impurity 11 REF: 4Z-F-3133	- - -	To inquire	Thu 19 Dec 24
Palbociclib Impurity 55 REF: 4Z-P-196062CAS: 2444702-87-6	- - -	To inquire	Thu 19 Dec 24
Lenvatinib Impurity 7 REF: 4Z-L-124010	- - -	To inquire	Thu 19 Dec 24
Palbociclib Impurity 70 REF: 4Z-P-196077	- - -	To inquire	Thu 19 Dec 24
Olaparib Impurity 56 REF: 4Z-O-032061	- - -	To inquire	Thu 19 Dec 24
Tamoxifen EP Impurity E REF: 4Z-T-0117	- - -	To inquire	Thu 19 Dec 24
Nintedanib Impurity 14 REF: 4Z-N-066028CAS: 1168152-06-4	- - -	To inquire	Thu 19 Dec 24
Abiraterone Impurity 7 REF: 4Z-A-8240CAS: 89878-14-8	- - -	To inquire	Thu 19 Dec 24

10mg		To inquire
25mg		To inquire
50mg		To inquire
100mg		To inquire

10mg		To inquire
25mg		To inquire
50mg		To inquire
100mg		To inquire

10mg		To inquire
25mg		To inquire
50mg		To inquire
100mg		To inquire

10mg		To inquire
25mg		To inquire
50mg		To inquire
100mg		To inquire

Cancer treatment

Nintedanib Impurity 76

Ref: 4Z-N-066087

Fulvestrant Impurity 6

Ref: 4Z-F-3120

Nintedanib Impurity 53

Ref: 4Z-N-066071

Lenvatinib Impurity 50

Ref: 4Z-L-124057

Leuprorelin (Leuprolide) EP Impurity J

Ref: 4Z-PL-4112

Olaparib Impurity 74

Ref: 4Z-O-032080

Olaparib Impurity 77

Ref: 4Z-O-032083

Carfilzomib Impurity 81

Ref: 4Z-C-121086

Olaparib Impurity 79

Ref: 4Z-O-032085

Olaparib Impurity 78

Ref: 4Z-O-032084

Enzalutamide Impurity 35

Ref: 4Z-E-068048

Olaparib Impurity 76

Ref: 4Z-O-032082

Fulvestrant Impurity 11

Ref: 4Z-F-3133

Palbociclib Impurity 55

Ref: 4Z-P-196062

Lenvatinib Impurity 7

Ref: 4Z-L-124010

Palbociclib Impurity 70

Ref: 4Z-P-196077

Olaparib Impurity 56

Ref: 4Z-O-032061

Tamoxifen EP Impurity E

Ref: 4Z-T-0117

Nintedanib Impurity 14

Ref: 4Z-N-066028

Abiraterone Impurity 7

Ref: 4Z-A-8240